Ling Tian

Author PubWeight™ 57.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012 1.96
2 Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 2003 1.95
3 Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res 2006 1.84
4 The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition. J Biol Chem 2003 1.56
5 Construction of a high-density genetic map based on large-scale markers developed by specific length amplified fragment sequencing (SLAF-seq) and its application to QTL analysis for isoflavone content in Glycine max. BMC Genomics 2014 1.30
6 Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res 2003 1.23
7 Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 2003 1.11
8 Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs. Carcinogenesis 2006 1.07
9 Genome-wide identification and characterization of ATP-binding cassette transporters in the silkworm, Bombyx mori. BMC Genomics 2011 1.02
10 Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells. FEBS Lett 2005 1.01
11 Transcriptional regulation of the insulin signaling pathway genes by starvation and 20-hydroxyecdysone in the Bombyx fat body. J Insect Physiol 2010 0.99
12 Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. J Immunol 2003 0.99
13 DPP-mediated TGFbeta signaling regulates juvenile hormone biosynthesis by activating the expression of juvenile hormone acid methyltransferase. Development 2011 0.98
14 Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma. Cancer Res 2012 0.98
15 Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia. Gynecol Endocrinol 2010 0.98
16 Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation. Oncol Res 2003 0.97
17 Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells. Breast Cancer Res 2011 0.95
18 Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. Cancer Res 2003 0.94
19 Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem 2003 0.93
20 TTRAP is a novel PML nuclear bodies-associated protein. Biochem Biophys Res Commun 2008 0.93
21 Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. Cancer Res 2006 0.93
22 Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Clin Cancer Res 2005 0.93
23 Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model. J Exp Clin Cancer Res 2008 0.92
24 MET is required for the maximal action of 20-hydroxyecdysone during Bombyx metamorphosis. PLoS One 2012 0.92
25 20-Hydroxyecdysone-induced transcriptional activity of FoxO upregulates brummer and acid lipase-1 and promotes lipolysis in Bombyx fat body. Insect Biochem Mol Biol 2013 0.91
26 Novel prognostic markers for patients with triple-negative breast cancer. Hum Pathol 2013 0.90
27 Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer. Int J Cancer 2004 0.90
28 PhiC31 integrase interacts with TTRAP and inhibits NFkappaB activation. Mol Biol Rep 2009 0.90
29 Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities. Oncology 2005 0.89
30 Chinese herbal medicines for induction of remission in advanced or late gastric cancer. Cochrane Database Syst Rev 2010 0.89
31 VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids. PLoS One 2013 0.86
32 Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. Anticancer Drugs 2005 0.86
33 Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma. Hum Pathol 2012 0.86
34 Sonic hedgehog signaling pathway supports cancer cell growth during cancer radiotherapy. PLoS One 2013 0.85
35 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors. J Control Release 2010 0.85
36 Cellular protein TTRAP interacts with HIV-1 integrase to facilitate viral integration. Biochem Biophys Res Commun 2009 0.84
37 Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer 2004 0.84
38 Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol 2004 0.84
39 The molecular mechanisms and therapeutic potential of microRNA-7 in cancer. Expert Opin Ther Targets 2014 0.84
40 TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway. Diabetes 2013 0.83
41 Role of TRIB3 in regulation of insulin sensitivity and nutrient metabolism during short-term fasting and nutrient excess. Am J Physiol Endocrinol Metab 2012 0.82
42 Drosophila CG10527 mutants are resistant to juvenile hormone and its analog methoprene. Biochem Biophys Res Commun 2010 0.81
43 Immunotherapy of tumors with recombinant adenovirus encoding macrophage inflammatory protein 3beta induces tumor-specific immune response in immunocompetent tumor-bearing mice. Acta Pharmacol Sin 2009 0.81
44 Daxx interacts with HIV-1 integrase and inhibits lentiviral gene expression. Biochem Biophys Res Commun 2008 0.81
45 Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor. J Immunother 2005 0.80
46 [Enhanced expression of human vimentin intermediate filaments in hepatocellular carcinoma cells decreases their proliferative and invasive abilities in vitro]. Zhonghua Zhong Liu Za Zhi 2008 0.80
47 Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models. Hum Gene Ther 2005 0.79
48 Development of chimeric gene regulators for cancer-specific gene therapy with both transcriptional and translational targeting. Mol Biotechnol 2010 0.79
49 Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3. Immunol Invest 2002 0.79
50 A homogeneous fluorescent sensor for human serum albumin. J Pharm Biomed Anal 2012 0.78
51 [Construction of mammalian co-expression plasmid pIRES -LMP1-HSP90 beta and its expression in vitro]. Sichuan Da Xue Xue Bao Yi Xue Ban 2006 0.78
52 Cancer immunotherapy of targeting angiogenesis. Cell Mol Immunol 2004 0.78
53 [Investigation on job stress of pediatricians and nurses working in pediatric department]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2008 0.78
54 [Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine]. Ai Zheng 2005 0.77
55 Molecular markers of therapeutic resistance in breast cancer. Hum Pathol 2013 0.77
56 [Epidemiological analysis of childhood cancer in China]. Zhongguo Dang Dai Er Ke Za Zhi 2015 0.76
57 Apoptosis mechanism of human cholangiocarcinoma cells induced by bile extract from crocodile. Appl Biochem Biotechnol 2011 0.76
58 [Fusion expression, purification and bioassay of IFN-gamma inducible protein-10 and thioredoxin gene in E. coli]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2005 0.76
59 Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals. Transplantation 2002 0.76
60 Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR. Cancer Immunol Immunother 2005 0.76
61 Phosphomimetic mutants of pigment epithelium-derived factor with enhanced anti-choroidal melanoma cell activity in vitro and in vivo. Invest Ophthalmol Vis Sci 2012 0.76
62 Vector retargeting for cancer gene therapy. Ai Zheng 2009 0.76
63 WITHDRAWN: Chinese herbal medicines for induction of remission in advanced or late gastric cancer. Cochrane Database Syst Rev 2011 0.75
64 Functional differentiation between Rep-mediated site-specific integration and transcriptional repression of the adeno-associated viral p5 promoter. Hum Gene Ther 2010 0.75
65 [Expression of xenogeneic homologous epidermal growth factor receptor ectodomain in Pichia pastoris]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005 0.75
66 [Construction of pcDNA-BLC and expression of BLC in tumor cells]. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 0.75
67 [Anti-tumor effects of recombinant adenovirus encoding survivin encapsulated in cationic liposome]. Sichuan Da Xue Xue Bao Yi Xue Ban 2006 0.75
68 [Screening and identification of stable transfectants of mouse soluble B lymphocyte stimulator]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2004 0.75
69 [Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2007 0.75
70 [Construction of pORF-mIG and activity evaluation of MIG in vitro]. Sichuan Da Xue Xue Bao Yi Xue Ban 2006 0.75
71 [Reconstruction and expression of recombinant lentiviral vector for human amelogenin in 293T cell line]. Shanghai Kou Qiang Yi Xue 2008 0.75
72 [Prokaryotic expression, purification and identification of recombinant Xenopus laevis and mouse vascular endothelial growth factors]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005 0.75
73 [Antitumor effect of recombinant Xenopus laevis vascular endothelial growth factor (VEGF) as a vaccine combined with adriamycin on EL4 lymphoma in mice]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005 0.75
74 [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination]. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 0.75
75 [Constructing the tumor cell vaccine based on homologous matrix metalloproteinase-2 and exploring its effects]. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 0.75
76 [Screening and identification of human nasopharyngeal carcinoma-associated antigens]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005 0.75
77 Inflammation-Related Pancreatic Carcinogenesis: Mechanisms and Clinical Potentials in Advances. Pancreas 2017 0.75
78 [Specific inhibition of Raf-1 gene expression in HNE1 by RNA interference]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006 0.75
79 [Effect of full-length cyclin B1 antisense cDNA on chemosensitivity of lewis lung carcinoma cells to gemicitabine in vitro and in vivo]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005 0.75
80 [Expression, purification and refolding of extracellular domain of mouse epidermal growth factor receptor]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2003 0.75
81 [Serological screening of xenogeneic antigens from rat testis]. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 0.75
82 [Control observation between mild moxibustion and TDP for obsolete collateral ligament injury of interphalangeal joints]. Zhongguo Zhen Jiu 2016 0.75
83 [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin]. Ai Zheng 2004 0.75
84 [Study on the expression of HSP70 and HSP90beta in nasopharyngeal carcinoma and the clinical significance]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005 0.75
85 [Key aromatic amino acids of anti-hepatoma activity on Parasporin-2]. Sheng Wu Gong Cheng Xue Bao 2013 0.75
86 The 156KELK159 tetrapeptide of HIV-1 integrase is critical for lentiviral gene integration. Mol Biol Rep 2011 0.75
87 [Prokaryotic expression of extracellular ligand binding domains of chick tie-2 and its anti-angiogenesis effect]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004 0.75
88 [Construction of recombinant adenovirus for the angiogenic inhibitor, vasostatin, and its expression in vitro]. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 0.75
89 [Expression and characterization of mouse 17-1A antigen from Pichia pastoris]. Sichuan Da Xue Xue Bao Yi Xue Ban 2006 0.75
90 [Transfection efficiency comparison of cationic liposome-DNA complexes and lipid-protamine-DNA complexes in vitro]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2007 0.75
91 [Nanobiotechnological gene transfer vectors in gene therapy]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2005 0.75
92 Expression of extracellular domain of human vascular endothelial growth factor receptor-2 in Pichia pastoris. Sichuan Da Xue Xue Bao Yi Xue Ban 2006 0.75
93 Apoptosis induced by aqueous extracts of crocodile bile in human heptacarcinoma SMMC-7721. Appl Biochem Biotechnol 2013 0.75
94 Detection methodology based on target molecule-induced sequence-specific binding to a single-stranded oligonucleotide. Anal Chem 2012 0.75
95 Isolation and purification of condensed tannins from flamboyant tree and their antioxidant and antityrosinase activities. Appl Biochem Biotechnol 2014 0.75
96 [Expression of isoleucine zipper modified soluble CD40L in Pichia pastoris]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2006 0.75
97 [Cloning human heat shock protein 90beta-cDNA and constructing its eukaryon vector]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2006 0.75
98 [Synthesis of N-[2-(cholesteryloxycarbonylamino) ethyl] carbamoylmethylated mannan]. Sichuan Da Xue Xue Bao Yi Xue Ban 2003 0.75
99 [Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice]. Ai Zheng 2005 0.75
100 [Construction of eukaryotic expression plasmid pSecTag2B-msBlyS expressing mouse soluble B lymphocyte stimulator]. Hua Xi Kou Qiang Yi Xue Za Zhi 2004 0.75
101 Aflatoxin testing in peanuts: a proficiency assessment scheme for Chinese analytic laboratories. J AOAC Int 2009 0.75
102 [Research and realization of signal processing algorithms based on FPGA in digital ophthalmic ultrasonography imaging]. Zhongguo Yi Liao Qi Xie Za Zhi 2015 0.75
103 Immunotherapy of tumor by targeting angiogenesis. Sci China C Life Sci 2004 0.75
104 [Experimental study of anti-cancer effect of Mannan-modified targeted nanoliposome on mice]. Sichuan Da Xue Xue Bao Yi Xue Ban 2006 0.75
105 The predictive role of p16 deletion, p53 deletion, and polysomy 9 and 17 in pancreatic ductal adenocarcinoma. Pathol Oncol Res 2012 0.75
106 [Prokaryotic expression, purification and refolding of extracellular ligand binding domains of chick Tie-2 and its immunogenicity]. Sichuan Da Xue Xue Bao Yi Xue Ban 2004 0.75
107 [Construction of the recombinant adenovirus vector expressing human CD40 ligand gene]. Hua Xi Kou Qiang Yi Xue Za Zhi 2005 0.75
108 Expression of the human fast-twitch skeletal muscle troponin I cDNA in a human ovarian carcinoma suppresses tumor growth. Sci China C Life Sci 2007 0.75